Journal of drug targeting · 2019 · 49 citations · 20 references
MedicineOncologyPharmacologyDrug DeliveryMolecular OncologyTargeted Drug DeliveryCancer NanomedicineHer2-positive Breast CancerNanocarriers For TherapeuticsNanomedicineTargeted Cancer TherapyTargeted TherapyActive Tumor TargetingCancer NanotherapyHer2-positive Breast Cancer TherapyHuman Epidermal Growth Factor Receptor 2-Targeted TherapyIn Vivo StudiesTrastuzumab ResistanceTumor Targeting LigandsTumor-targeted Drug Delivery
Increased human epidermal growth factor receptor 2 (HER2) expression is a hallmark of HER2+ breast cancer. HER2 promotes the growth of cancer cells and makes them particularly aggressive. Currently, trastuzumab is the only HER2-targeted therapeutic agent approved by the FDA for HER2-overexpressing breast cancer treatment. However, clinical efficacy of trastuzumab is limited greatly by the occurrence of drug resistance. In this study, an aptamer (HA1) specific for HER2-overexpressing breast cancer cells was selected using Cell-SELEX. This allowed the development of grapefruit-derived nanovectors (GNVs) conjugated with HA1 that targeted specifically HER2+ breast cancer cells. In vitro experiments demonstrated that HA1 effectively promoted the internalisation of GNVs into cancer cells and tumour spheroids. In vivo data showed that drug delivery to tumour tissues and antitumor activities were dramatically enhanced by conjugating HA1 with drug-loaded GNVs. This study indicates that aptamers mediating targeted drug delivery by GNVs represent a promising strategy for HER2+ breast cancer therapy.
20
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Martine Piccart, Marion Procter, Brian Leyland‐Jones et al. · New England Journal of Medicine · 2005 · 5.1K citations · Full text
Medicine, Oncology, Pharmacology +16
Silica and titanium dioxide nanoparticles cause pregnancy complications in mice
Kohei Yamashita, Yasuo Yoshioka, Kazuma Higashisaka et al. · Nature Nanotechnology · 2011 · 739 citations
Medicine, Gynecology, Obstetrics +14
Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids
Qilong Wang, Xiaoying Zhuang, Jingyao Mu et al. · Nature Communications · 2013 · 505 citations · Full text